Answers are grounded in this paper and cite their sources.
The treatment landscape for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) has evolved with tyrosine kinase inhibitors (TKIs) [1,2], spanning intensive chemotherapy–TKI co...
No takes yet. Share an insight, caveat, or question.
Endo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: